Older women and hormone replacement therapy: Factors influencing late life initiation

被引:22
作者
Leveille, SG
LaCroix, AZ
Newton, KM
Keenan, NL
机构
[1] UNIV WASHINGTON,SCH PUBL HLTH & COMMUNITY MED,NW PREVENT EFFECTIVENESS CTR,SEATTLE,WA 98195
[2] UNIV WASHINGTON,CTR HLTH STUDIES,GRP HLTH COOPERAT PUGET SOUND,SEATTLE,WA 98195
[3] FRED HUTCHINSON CANC RES CTR,DIV PUBL HLTH SCI,SEATTLE,WA 98104
[4] CTR DIS CONTROL & PREVENT,ATLANTA,GA
关键词
D O I
10.1111/j.1532-5415.1997.tb03201.x
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
OBJECTIVE: To describe factors associated with initiation of hormone replacement therapy (HRT) by older women, DESIGN: A cross-sectional study of 671 randomly selected women aged 65 to 80 who participated in a larger telephone survey on preventive health behaviors. SETTING: A large health maintenance organization (HMO) in Seattle, Washington. PARTICIPANTS: Of the 521 women who responded (78%), 51 had begun taking HRT at age 60 or older and were identified as initiators. Women who had never used HRT or past users who had begun HRT before age 60 were classified as noninitiators (n = 362). Current users who started HRT before age 60 (n = 108) were excluded. MEASUREMENTS: Sources included the telephone survey, automated HMO pharmacy data, and HMO utilization and provider databases. RESULTS: Initiators were similar to noninitiators with respect to age, marital status, education, and health status. Initiators were more likely to have had a hysterectomy at age 60 or later than noninitiators. Sixty-two percent of the noninitiators said they had received no information about the benefits of HRT from their providers compared with 18% of initiators. HRT initiation was associated with belief in prevention benefits of HRT for fractures and cardiovascular disease and with reported encouragement from the physician to use HRT. CONCLUSIONS: Other than hysterectomy status, there were few sociodemographic or health characteristics that markedly distinguished older initiators from noninitiators. Our findings show the importance of physician counseling in an older woman's decision to initiate HRT.
引用
收藏
页码:1496 / 1500
页数:5
相关论文
共 28 条
[1]  
Barrett-Connor E., 1995, J WOMENS HEALTH, V4, P143
[2]   PREVALENCE AND DETERMINANTS OF ESTROGEN REPLACEMENT THERAPY IN ELDERLY WOMEN [J].
CAULEY, JA ;
CUMMINGS, SR ;
BLACK, DM ;
MASCIOLI, SR ;
SEELEY, DG .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 163 (05) :1438-1444
[3]   17-BETA-ESTRADIOL AND CONTINUOUS NORETHISTERONE - A UNIQUE TREATMENT FOR ESTABLISHED OSTEOPOROSIS IN ELDERLY WOMEN [J].
CHRISTIANSEN, C ;
RIIS, BJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 71 (04) :836-841
[4]   HRT - AN ANALYSIS OF BENEFITS, RISKS AND COSTS [J].
DALY, E ;
ROCHE, M ;
BARLOW, D ;
GRAY, A ;
MCPHERSON, K ;
VESSEY, M .
BRITISH MEDICAL BULLETIN, 1992, 48 (02) :368-400
[5]   THE WANING EFFECT OF POSTMENOPAUSAL ESTROGEN THERAPY ON OSTEOPOROSIS [J].
ETTINGER, B ;
GRADY, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (16) :1192-1193
[6]   ESTROGEN REPLACEMENT THERAPY - A SURVEY OF WOMENS KNOWLEDGE AND ATTITUDES [J].
FERGUSON, KJ ;
HOEGH, C ;
JOHNSON, S .
ARCHIVES OF INTERNAL MEDICINE, 1989, 149 (01) :133-136
[7]   THE EPIDEMIOLOGY OF CORONARY HEART-DISEASE AND ESTROGEN REPLACEMENT IN POSTMENOPAUSAL WOMEN [J].
GRODSTEIN, F ;
STAMPFER, M .
PROGRESS IN CARDIOVASCULAR DISEASES, 1995, 38 (03) :199-210
[8]  
GROENEVELD FPM, 1995, MATURITAS, V20, P81
[9]  
Handa VL, 1996, J AM GERIATR SOC, V44, P1
[10]   ESTROGEN REPLACEMENT THERAPY AND PROTECTION FROM ACUTE MYOCARDIAL-INFARCTION [J].
HENDERSON, BE ;
PAGANINIHILL, A ;
ROSS, RK .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1988, 159 (02) :312-317